Table 2 Summary of diseases developed in BCR-ABL-GFP and BCR-ABL-GFP + N17 H-Ras mice
From: Effect of Ras Inhibition in Hematopoiesis and BCR/ABL Leukemogenesis
Mice | CML | B-lymphoid leukemia/lymphoma | ND* |
|---|---|---|---|
BCR-ABL-GFP | 7/7 | 0/7 | - |
BCR-ABL-GFP+ N17 H-Ras | 2/12 | 8/12 | 2/12 |